Christophe Dooms

11.7k total citations · 3 hit papers
142 papers, 4.6k citations indexed

About

Christophe Dooms is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Christophe Dooms has authored 142 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Pulmonary and Respiratory Medicine, 41 papers in Oncology and 28 papers in Surgery. Recurrent topics in Christophe Dooms's work include Lung Cancer Diagnosis and Treatment (66 papers), Lung Cancer Treatments and Mutations (51 papers) and Tracheal and airway disorders (21 papers). Christophe Dooms is often cited by papers focused on Lung Cancer Diagnosis and Treatment (66 papers), Lung Cancer Treatments and Mutations (51 papers) and Tracheal and airway disorders (21 papers). Christophe Dooms collaborates with scholars based in Belgium, United States and Netherlands. Christophe Dooms's co-authors include Johan Vansteenkiste, Paul De Leyn, Jonas Yserbyt, Dirk Van Raemdonck, Ramón Rami–Porta, Paul Van Schil, Kurt G. Tournoy, Natalie Lorent, Eric Verbeken and Herbert Decaluwé and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Christophe Dooms

136 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer

2014 521 citations Paul De Leyn, Christophe Dooms et al. profile →
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer

2023 460 citations Heather A. Wakelee, Moïshe Liberman et al. profile →
Mediastinoscopy vs Endosonography for Mediastinal Nodal Staging of Lung Cancer

2010 370 citations Robert C. Rintoul, Christophe Dooms et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christophe Dooms Belgium	36	3.7k	1.1k	1.1k	782	397	142	4.6k
Alexander V. Louie Canada	37	3.1k 0.8×	1.4k 1.2×	1.1k 1.0×	750 1.0×	423 1.1×	266	4.4k
Morihito Okada Japan	40	6.2k 1.7×	1.8k 1.6×	1.5k 1.4×	1.2k 1.6×	341 0.9×	280	7.1k
Mathias Bressel Australia	35	1.7k 0.5×	1.0k 0.9×	1.4k 1.2×	789 1.0×	347 0.9×	184	3.8k
Hisashi Saji Japan	38	3.9k 1.1×	1.3k 1.1×	1.7k 1.5×	641 0.8×	483 1.2×	130	5.6k
Jeremy J. Erasmus United States	33	3.1k 0.8×	1.6k 1.4×	863 0.8×	1.1k 1.4×	224 0.6×	97	4.3k
Reza J. Mehran United States	45	4.4k 1.2×	807 0.7×	1.4k 1.2×	2.6k 3.3×	307 0.8×	276	6.6k
Daniel J. Boffa United States	33	4.1k 1.1×	858 0.8×	2.2k 1.9×	1.4k 1.8×	461 1.2×	166	6.3k
Gary M. Strauss United States	31	4.5k 1.2×	1.0k 0.9×	1.8k 1.6×	398 0.5×	291 0.7×	103	5.4k
David E. Midthun United States	35	4.9k 1.3×	2.6k 2.3×	1.2k 1.1×	769 1.0×	268 0.7×	114	6.5k
Michael MacManus Australia	36	2.3k 0.6×	2.3k 2.0×	1.2k 1.1×	431 0.6×	377 0.9×	148	4.5k

Countries citing papers authored by Christophe Dooms

Since Specialization

Citations

This map shows the geographic impact of Christophe Dooms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Dooms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Dooms more than expected).

Fields of papers citing papers by Christophe Dooms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Dooms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Dooms. The network helps show where Christophe Dooms may publish in the future.

Co-authorship network of co-authors of Christophe Dooms

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Dooms. A scholar is included among the top collaborators of Christophe Dooms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Dooms. Christophe Dooms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wakelee, Heather A., Shugeng Gao, Moïshe Liberman, et al.. (2025). LBA67 Perioperative pembrolizumab in early-stage non-small- cell lung cancer (NSCLC): 5-year follow-up from KEYNOTE- 671. Annals of Oncology. 36. S1607–S1608.

Goldman, Jonathan W., Christophe Dooms, Komal Jhaveri, et al.. (2024). Neratinib Efficacy in Patients With EGFR Exon 18-Mutant Non-Small-Cell Lung Cancer: Findings From the SUMMIT Basket Trial. Clinical Lung Cancer. 26(3). 191–200.e1. 1 indexed citations

Chaddha, Udit, Abhinav Agrawal, Jonathan S. Kurman, et al.. (2024). World Association for Bronchology and Interventional Pulmonology (WABIP) guidelines on airway stenting for malignant central airway obstruction. Respirology. 29(7). 563–573. 5 indexed citations

Jones, David R., Moïshe Liberman, Terufumi Kato, et al.. (2024). OA01.03 Association of Pathologic Regression with EFS in the KEYNOTE-671 Study of Perioperative Pembrolizumab for Early-Stage NSCLC. Journal of Thoracic Oncology. 19(10). S8–S8. 5 indexed citations

Negrão, Marcelo V., Philippe A. Cassier, Benjamin Solomon, et al.. (2023). MA06.03 KontRASt-01: Preliminary Safety and Efficacy of JDQ443 + TNO155 in Patients with Advanced, KRAS G12C-Mutated Solid Tumors. Journal of Thoracic Oncology. 18(11). S117–S118. 16 indexed citations

Aerts, Robina, et al.. (2022). Hemolytic anemia caused by alectinib, an Anaplastic Lymphoma Kinase (ALK) inhibitor: A case report. SHILAP Revista de lepidopterología. 7. 100176–100176. 1 indexed citations

Kalkanis, Alexandros, Els Wauters, Dries Testelmans, et al.. (2021). Early lung ultrasound assessment for the prognosis of patients hospitalized for COVID-19 pneumonia. A pilot study. Respiratory Medicine and Research. 80. 100832–100832. 2 indexed citations

Rami–Porta, Ramón, Sergi Call, Christophe Dooms, et al.. (2018). Lung cancer staging: a concise update. European Respiratory Journal. 51(5). 1800190–1800190. 94 indexed citations

Billiet, Charlotte, Dirk De Ruysscher, Stéphanie Peeters, et al.. (2016). Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target Volumes. Journal of Thoracic Oncology. 11(9). 1538–1549. 15 indexed citations

10.

Billiet, Charlotte, Stéphanie Peeters, Herbert Decaluwé, et al.. (2016). Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypN0 Stage III-N2 NSCLC after Induction Chemotherapy and Resection. Journal of Thoracic Oncology. 11(11). 1940–1953. 12 indexed citations

11.

Louis, Evelyne, Peter Adriaensens, Wanda Guedens, et al.. (2016). Detection of Lung Cancer through Metabolic Changes Measured in Blood Plasma. Journal of Thoracic Oncology. 11(4). 516–523. 59 indexed citations

12.

Reynders, Kobe, Els Wauters, Johan Vansteenkiste, et al.. (2015). Transcriptome Sequencing of Tumor vs. Surrounding Non-Malignant Lung Tissue in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 10(9). 1 indexed citations

13.

Yserbyt, Jonas, Lieven Dupont, Vincent Ninane, & Christophe Dooms. (2015). To Boldly Go Where No Bronchoscope Has Gone Before. American Journal of Respiratory and Critical Care Medicine. 191(8). 956–956. 1 indexed citations

14.

Dooms, Christophe, et al.. (2013). Endobronchial ultrasound in the management of nonsmall cell lung cancer. European Respiratory Review. 22(128). 169–177. 12 indexed citations

15.

Billiet, Charlotte, Herbert Decaluwé, Stéphanie Peeters, et al.. (2013). MODERN POST-OPERATIVE RADIOTHERAPY FOR STAGE III NON-SMALL CELL LUNG CANCER MAY IMPROVE LOCAL CONTROL AND SURVIVAL: A PUBLICATION-BASED META-ANALYSIS. Journal of Thoracic Oncology. 8. 1 indexed citations

16.

Yserbyt, Jonas, Christophe Dooms, Marc Decramer, & Geert M. Verleden. (2013). Probe-based confocal laser endomicroscopy of the respiratory tract: A data consistency analysis. Respiratory Medicine. 107(8). 1234–1240. 9 indexed citations

17.

Sharples, Linda, Christopher Jackson, Gemma M. Griffith, et al.. (2012). Clinical effectiveness and cost-effectiveness of endobronchial and endoscopic ultrasound relative to surgical staging in potentially resectable lung cancer: results from the ASTER randomised controlled trial.. Health Technology Assessment. 16(18). 1–75, iii. 99 indexed citations

18.

Sibille, Anne, et al.. (2012). MAINTENANCE THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER: HOW DOES MY PATIENT FEEL ABOUT IT?. Journal of Thoracic Oncology. 7(6). 1 indexed citations

19.

Yserbyt, Jonas, Christophe Dooms, Wim Janssens, et al.. (2011). Probe-based confocal laser endomicroscopy in acute lung allograft rejection. European Respiratory Journal. 38(Suppl 55). p2443–p2443. 1 indexed citations

20.

Lorent, Natalie, Paul De Leyn, Yolande Lievens, et al.. (2004). Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience. Annals of Oncology. 15(11). 1645–1653. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact